IVERIC bio Inc. Stock
Your prediction
IVERIC bio Inc. Stock
Our community identified positive and negative aspects for IVERIC bio Inc. stock for the coming years. 2 users see the criterium "Worthwhile Investment for the next years" as a plus for the IVERIC bio Inc. stock. On the other hand our users think that "Management" could be a problem in the future.
Pros and Cons of IVERIC bio Inc. in the next few years
Pros
?
S********** s********
?
B****
?
G***** c******* t* c**********
Cons
?
C******** o* t** e**********
?
M***** P*******
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of IVERIC bio Inc. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
IVERIC bio Inc. | - | - | - | - | - | - | - |
Vaxart Inc. | 4.300% | -10.926% | -8.902% | 5.482% | 39.934% | -89.660% | - |
Larimar Therapeutics Inc. | -0.890% | -11.111% | -20.000% | 39.303% | 37.255% | -46.667% | -27.649% |
aTyr Pharma Inc | - | -10.651% | -8.485% | 2.027% | 17.054% | -85.755% | -55.060% |
Comments
IVERIC bio, Inc. (NASDAQ: ISEE) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for ISEE provided by MarketBeat
IVERIC bio, Inc. (NASDAQ: ISEE) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for ISEE provided by MarketBeat
IVERIC bio, Inc. (NASDAQ: ISEE) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for ISEE provided by MarketBeat